Plain-English translation of NCT07230353 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called as a potential treatment for rheumatoid arthritis. Researchers want to understand how safe this medication is, how your body processes it, and how it works to reduce arthritis symptoms. About 68 people with moderate to severe rheumatoid arthritis will receive different doses of the medication by injection to find the best dose and check for side effects.
Current treatments for rheumatoid arthritis don't work well for everyone — some people don't respond to available medications, lose their response over time, or can't tolerate them. This trial is exploring whether this new treatment could help people with rheumatoid arthritis who need better options.
You likely qualify if…
You likely don't qualify if…
You would receive injections of the medication under your skin at different doses as part of a dose-escalation study — meaning the dose increases over time as researchers learn it is safe. You would attend visits to receive your injections, have blood tests to check how your body handles the medication, and report any side effects or changes in your symptoms. The study will help researchers determine the safest and most effective dose for future testing.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Georgia
Moldova
New Zealand